Calcium Chloride

CHEMBL1200668 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
111.0 g/mol
LogP
Phase
4

An injectable calcium salt used in emergency medicine to treat severe hypocalcemia, hyperkalemia, and calcium channel blocker overdose. It provides a higher concentration of elemental calcium per volume than calcium gluconate, making it preferred in critical settings. Extravasation can cause severe tissue damage, requiring careful intravenous administration.

Peso Molecular

110,9800 g/mol

TPSA

0,00 Ų

Áreas Terapêuticas

Mecanismo de Ação

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[Ca+2].[Cl-].[Cl-]

InChI

InChI=1S/Ca.2ClH/h;2*1H/q+2;;/p-2

Molecular Formula

CaCl2

HBD / HBA

- / 2

Ligações Rotacionáveis

0

Átomos Pesados

3

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

An injectable calcium salt used in emergency medicine to treat severe hypocalcemia, hyperkalemia, and calcium channel blocker overdose. It provides a higher concentration of elemental calcium per volume than calcium gluconate, making it preferred in critical settings. Extravasation can cause severe tissue damage, requiring careful intravenous administration.

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Yes, Calcium Chloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200668. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5284359. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.